Prof. Guillermo Velasco

Guillermo Velasco studied Biology (1988-1993) and carried out his doctoral thesis at the Department of Biochemistry and Molecular Biology I of the Faculty of Chemical Sciences of the Complutense University under the direction of Dr. Manuel Guzmán (1994-1997) on the subject: "Regulatory mechanisms of fatty acid oxidation in rat liver". Subsequently, he carried out a post-doctoral stay financed by an EMBO grant in the laboratory of Dr. Philip Cohen (1998-1999) at the University of Dundee, Scotland, where he studied the role of Rho Kinase in the regulation of muscle contraction. smooth and was able to become familiar with the study of cell signaling mechanisms. In 1999 he rejoined the Department of Biochemistry and since February 2008 Guillermo Velasco is Associate Professor of the Department of Biochemistry and Molecular Biology at the Complutense University, Madrid. Starting in 2001 and within the Cannabinoid Signaling Group, Guillermo Velasco developed a line of research focused on the study of the molecular mechanisms underlying the antitumor action of cannabinoids, as well as optimizing the conditions of use of these agents for possible clinical application. Likewise, Guillermo is head of the group "Signaling by cannabinoids in tumor cells" at the San Carlos Health Research Institute. Since 2020 Guillermo has become the research coordinator of the Translational Oncology laboratory of the San Carlos Clinical Hospital.